54 research outputs found
Evaluation of host and viral factors associated with severe dengue based on the 2009 WHO classification
The importance of effective risk communication and transparency: lessons from the dengue vaccine controversy in the Philippines
In 2016 the Philippine Department of Health (DOH) introduced a novel dengue vaccine in a mass immunization program to reduce the substantial economic and social burden of the disease on households and the government. The vaccine manufacturer’s announcement regarding new findings on the small but increased risk of severe dengue for vaccinated seronegative patients caused turmoil as various people claimed that the vaccine caused deaths and that health authorities are corrupt. While health department staff split—some having to preserve its reputation and others to monitor over 800,000 children administered the vaccine—communication between the frontline health workers and parents suffered. As a result, public confidence in vaccines dramatically dropped and the repercussions challenge the public health system. We examine factors that contributed to the crisis and argue for strengthening risk communication strategies and increasing transparency on decision making to counter misinformation and protect public health
Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design
Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
Analyzing Media Coverage of the Global Fund Diseases Compared with Lower Funded Diseases (Childhood Pneumonia, Diarrhea and Measles)
- …